The Europe cerebrospinal fluid management market is expected to reach US$ 988.78 million by 2028 from US$ 694.04 million in 2021; it is estimated to grow at a CAGR of 5.2% from 2021 to 2028.
The growth of the market is attributed to rising technological developments for CSF shunts and growing developments for CSF management products. However, the risk associated with CSF shunts hinders the market growth.
The never-ending technological developments are the unstoppable trend for the growth of CSF management market. The risk of diagnosing and treatment failure, limited control options, and complications have offered various opportunities for the product developers. Rising advancements in technology have introduced the concept of “smart shunt” that could offer hi-tech control, diagnosis, and communication-based shunts or implants. It is anticipated that designed smart shunts can control CSF drainage based on feedback from one or more measured conditions. Additionally, researchers expect that smart shunts have the potential to offer sophisticated control over mechanical shunts—data with respect to shunt malfunction. It is further expected to reduce the risk of shunt obstructions and eventually reduce the risk of failures.
Late-stage development companies operating in the market are demanding experimental results to seek approvals and commercialize the smart shunts. The primary focus is on shunts designed to assess ICP noninvasively in the physician’s office through an implanted pressure sensor and noninvasive assessment of CSF flow in the clinical settings. These on-demand sensing systems will be a significantly advanced supplement to existing mechanical valves.
The growing demand for better treatments has resulted in various product developments, resulting in the Europe cerebrospinal fluid management market growth. For instance, in July 2018, FDA granted breakthrough device designation to F. Hoffmann-La Roche Ltd for its Elecsys ß-Amyloid (1-42) CSF and Elecsys Phospho-Tau (181P) CSF. The products are used as in-vitro diagnostic immunoassays to measure ß-Amyloid (1-42) and Phospho-Tau concentrations in CSF among adults with cognitive impairment. They are evaluated for Alzheimer’s disease (AD) and other causes of dementia.
The European economy is severely affected due to the exponential growth of COVID-19 cases in the region. Spain, Italy, Germany, France, and the UK are among the most-affected European countries. The COVID-19 emergency has undoubtedly aided in encouraging the general population to try out and expand their usage of digital services, particularly to avoid visiting a health center in person. However, there are still a number of constraints that hinder these services from becoming widely adopted.
Inconsistent and interrupted supply chain activities and unavailability of human resources negatively impacted the cerebrospinal fluid management market growth. The sudden onset of pandemic led to shutdown of neurological wards and clinics across numerous countries. At the same time, hospitals ran out of resources owing to a huge number of COVID-19 patients. Consequently, according to one study, many diagnostic and treatment procedures had been cancelled or postponed around the world.
Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2028 (US$ Mn)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities

- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
EUROPE CEREBROSPINAL FLUID MANAGEMENT MARKET SEGMENTATION
By Product
- CSF shunts
- CSF drainage systems
By End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Neurological Centers
By Country
- U.K.
- Germany
- France
- Italy
- Spain
- Rest of Europe
Company Profiles
- Medtronic
- Integra Life Sciences Corporation
- B. Braun Melsungen AG
- DePuy Synthes
- Sophysa
- Dispomedica GmbH
- Möller Medical GmbH
- Natus Medical Incorporated
- Spiegelberg GmbH & Co. KG

Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
This text is related
to segments covered.

Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
This text is related
to country scope.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Cerebrospinal Fluid Management Market – By Product
1.3.2 Cerebrospinal Fluid Management Market – By End User
1.3.3 Cerebrospinal Fluid Management Market – By Country
2. Cerebrospinal Fluid Management Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Cerebrospinal Fluid Management Market– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe: PEST Analysis
4.3 Expert Opinion
5. Cerebrospinal Fluid Management Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Incidences of CSF Leak
5.1.2 Growing Developments for CSF Management Products
5.2 Market Restraints
5.2.1 Risk Associated with CSF Shunts
5.3 Future Trends
5.3.1 Technological Developments for CSF Shunts
5.4 Impact Analysis
6. Cerebrospinal Fluid Management Market – Europe Analysis
6.1 Europe Cerebrospinal Fluid Management Marker Revenue Forecast and Analysis
7. Cerebrospinal Fluid Management Market Analysis – By Product
7.1 Overview
7.2 Cerebrospinal Fluid Management Market Revenue Share, by Product (2021 and 2028)
7.3 CSF Shunts
7.3.1 Overview
7.3.2 CSF Shunts: Cerebrospinal Fluid Management Market– Revenue and Forecast to 2028 (US$ Million)
7.3.3 Ventriculo-Peritoneal Shunts
7.3.3.1 Overview
7.3.3.2 Ventriculo-Peritoneal Shunts: Cerebrospinal Fluid Management Market– Revenue and Forecast to 2028 (US$ Million)
7.3.4 Ventriculo-Atrial Shunts
7.3.4.1 Overview
7.3.4.2 Ventriculo-Atrial Shunts: Cerebrospinal Fluid Management Market– Revenue and Forecast to 2028 (US$ Million)
7.3.5 Ventriculo-Pleural Shunts
7.3.5.1 Overview
7.3.5.2 Ventriculo-Pleural Shunts: Cerebrospinal Fluid Management Market– Revenue and Forecast to 2028 (US$ Million)
7.3.6 Lumbo-Peritoneal Shunts
7.3.6.1 Overview
7.3.6.2 Lumbo-Peritoneal Shunts: Cerebrospinal Fluid Management Market– Revenue and Forecast to 2028 (US$ Million)
7.4 CSF Drainage Systems
7.4.1 Overview
7.4.2 CSF Drainage Systems: Cerebrospinal Fluid Management Market– Revenue and Forecast to 2028 (US$ Million)
7.4.3 xternal Ventricular Drainage (EVD) Systems
7.4.3.1 Overview
7.4.3.2 External Ventricular Drainage (EVD) Systems: Cerebrospinal Fluid Management Market– Revenue and Forecast to 2028 (US$ Million)
7.4.4 Lumbar Drainage (LD) Systems
7.4.4.1 Overview
7.4.4.2 Lumbar Drainage (LD) Systems: Cerebrospinal Fluid Management Market– Revenue and Forecast to 2028 (US$ Million)
8. Cerebrospinal Fluid Management Market Analysis – By End User
8.1 Overview
8.2 Cerebrospinal Fluid Management Market Revenue Share, by End User (2021 and 2028)
8.3 Hospitals
8.3.1 Overview
8.3.2 Hospitals: Cerebrospinal Fluid Management Market– Revenue and Forecast to 2028 (US$ Million)
8.4 Clinics
8.4.1 Overview
8.4.2 Clinics: Cerebrospinal Fluid Management Market– Revenue and Forecast to 2028 (US$ Million)
8.5 Ambulatory Surgical Centers
8.5.1 Overview
8.5.2 Ambulatory Surgical Centers: Cerebrospinal Fluid Management Market– Revenue and Forecast to 2028 (US$ Million)
8.6 Neurological Centers
8.6.1 Overview
8.6.2 Neurological Centers: Cerebrospinal Fluid Management Market– Revenue and Forecast to 2028 (US$ Million)
9. Cerebrospinal Fluid Management Market – Europe Analysis
9.1 Europe: Cerebrospinal Fluid Management Market
9.1.1 Overview
9.1.2 Europe: Cerebrospinal Fluid Management Market - Revenue and forecast to 2028 (USD Million)
9.1.3 Europe: Cerebrospinal Fluid Management Market, by Product, 2019–2028 (USD Million)
9.1.3.1 Europe Cerebrospinal Fluid Management Market, by CSF Shunts, 2019–2028 (USD Million)
9.1.3.2 Europe Cerebrospinal Fluid Management Market, by CSF Drainage Systems, 2019–2028(USD Million)
9.1.4 Europe: Cerebrospinal Fluid Management Market, by End User, 2019–2028 (USD Million)
9.1.5 Europe: Cerebrospinal Fluid Management Market, by Country, 2021 & 2028 (%)
9.1.5.1 Germany: Cerebrospinal Fluid Management Market – Revenue and forecast to 2028 (USD Million)
9.1.5.1.1 Germany: Cerebrospinal Fluid Management Market – Revenue and forecast to 2028 (USD Million)
9.1.5.1.2 Germany: Cerebrospinal Fluid Management Market, by Product, 2019–2028 (USD Million)
9.1.5.1.2.1 Germany Cerebrospinal Fluid Management Market, by CSF Shunts, 2019–2028 (USD Million)
9.1.5.1.2.2 Germany Cerebrospinal Fluid Management Market, by CSF Drainage Systems, 2019–2028 (USD Million)
9.1.5.1.3 Germany: Cerebrospinal Fluid Management Market, by End User, 2019–2028 (USD Million)
9.1.5.2 UK: Cerebrospinal Fluid Management Market – Revenue and forecast to 2028 (USD Million)
9.1.5.2.1 UK: Cerebrospinal Fluid Management Market – Revenue and forecast to 2028 (USD Million)
9.1.5.2.2 UK: Cerebrospinal Fluid Management Market, by Product, 2019–2028 (USD Million)
9.1.5.2.2.1 UK Cerebrospinal Fluid Management Market, by CSF Shunts, 2019–2028 (USD Million)
9.1.5.2.2.2 UK Cerebrospinal Fluid Management Market, by CSF Drainage Systems, 2019–2028 (USD Million)
9.1.5.2.3 UK: Cerebrospinal Fluid Management Market, by End User, 2019–2028 (USD Million)
9.1.5.3 France: Cerebrospinal Fluid Management Market – Revenue and forecast to 2028 (USD Million)
9.1.5.3.1 France: Cerebrospinal Fluid Management Market – Revenue and forecast to 2028 (USD Million)
9.1.5.3.2 France: Cerebrospinal Fluid Management Market, by Product, 2019–2028 (USD Million)
9.1.5.3.2.1 France Cerebrospinal Fluid Management Market, by CSF Shunts, 2019–2028 (USD Million)
9.1.5.3.2.2 France Cerebrospinal Fluid Management Market, by CSF Drainage Systems, 2019–2028 (USD Million)
9.1.5.3.3 France: Cerebrospinal Fluid Management Market, by End User, 2019–2028 (USD Million)
9.1.5.4 Spain: Cerebrospinal Fluid Management Market – Revenue and forecast to 2028 (USD Million)
9.1.5.4.1 Spain: Cerebrospinal Fluid Management Market – Revenue and forecast to 2028 (USD Million)
9.1.5.4.2 Spain: Cerebrospinal Fluid Management Market, by Product, 2019–2028 (USD Million)
9.1.5.4.2.1 Spain Cerebrospinal Fluid Management Market, by CSF Shunts, 2019–2028 (USD Million)
9.1.5.4.2.2 Spain Cerebrospinal Fluid Management Market, by CSF Drainage Systems, 2019–2028 (USD Million)
9.1.5.4.3 Spain: Cerebrospinal Fluid Management Market, by End User, 2019–2028 (USD Million)
9.1.5.5 Italy: Cerebrospinal Fluid Management Market – Revenue and forecast to 2028 (USD Million)
9.1.5.5.1 Italy: Cerebrospinal Fluid Management Market – Revenue and forecast to 2028 (USD Million)
9.1.5.5.2 Italy: Cerebrospinal Fluid Management Market, by Product, 2019–2028 (USD Million)
9.1.5.5.2.1 Italy Cerebrospinal Fluid Management Market, by CSF Shunts, 2019- 2028 (USD Million)
9.1.5.5.2.2 Italy Cerebrospinal Fluid Management Market, by CSF Drainage Systems, 2019–2028 (USD Million)
9.1.5.5.3 Italy: Cerebrospinal Fluid Management Market, by End User, 2019–2028 (USD Million)
9.1.5.6 Rest of Europe: Cerebrospinal Fluid Management Market – Revenue and forecast to 2028 (USD Million)
9.1.5.6.1 Rest of Europe: Cerebrospinal Fluid Management Market – Revenue and forecast to 2028 (USD Million)
9.1.5.6.2 Rest of Europe: Cerebrospinal Fluid Management Market, by Product, 2019–2028 (USD Million)
9.1.5.6.2.1 Rest of Europe Cerebrospinal Fluid Management Market, by CSF Shunts, 2019-2028 (USD Million)
9.1.5.6.2.2 Rest of Europe Cerebrospinal Fluid Management Market, by CSF Drainage Systems, 2019–2028 (USD Million)
9.1.5.6.3 Rest of Europe: Cerebrospinal Fluid Management Market, by End User, 2019–2028 (USD Million)
10. Impact of COVID-19 Pandemic on Europe Cerebrospinal Fluid Management Market
10.1 Europe: Impact Assessment of COVID-19 Pandemic
11. Cerebrospinal Fluid Management Market–Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 Medtronic
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Integra Life Sciences Corporation
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 B. Braun Melsungen AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 DePuy Synthes
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Sophysa
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Dispomedica GmbH
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Möller Medical GmbH
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Natus Medical Incorporated
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Spiegelberg GmbH & Co. KG
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About the Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Europe Cerebrospinal Fluid Management Market, by Product– Revenue and forecast to 20280(USD Million)
Table 2. Europe Cerebrospinal Fluid Management Market, by CSF Shunts – Revenue and Forecast to 2028 (USD Million)
Table 3. Europe Cerebrospinal Fluid Management Market, by CSF Drainage Systems – Revenue and Forecast to 2028 (USD Million)
Table 4. Europe Cerebrospinal Fluid Management Market, by End User – Revenue and forecast to 2028 (USD Million)
Table 5. Germany Cerebrospinal Fluid Management Market, by Product– Revenue and forecast to 2028 (USD Million)
Table 6. Germany Cerebrospinal Fluid Management Market, by CSF Shunts – Revenue and Forecast to 2028 (USD Million)
Table 7. Germany Cerebrospinal Fluid Management Market, by CSF Drainage Systems – Revenue and Forecast to 2028 (USD Million)
Table 8. Germany Cerebrospinal Fluid Management Market, by End User – Revenue and forecast to 2028 (USD Million)
Table 9. UK Cerebrospinal Fluid Management Market, by Product– Revenue and forecast to 2028 (USD Million)
Table 10. UK Cerebrospinal Fluid Management Market, by CSF Shunts – Revenue and Forecast to 2028 (USD Million)
Table 11. UK Cerebrospinal Fluid Management Market, by CSF Drainage Systems – Revenue and Forecast to 2028 (USD Million)
Table 12. UK Cerebrospinal Fluid Management Market, by End User – Revenue and forecast to 2028 (USD Million)
Table 13. France Cerebrospinal Fluid Management Market, by Product– Revenue and forecast to 2028 (USD Million)
Table 14. France Cerebrospinal Fluid Management Market, by CSF Shunts – Revenue and Forecast to 2028 (USD Million)
Table 15. France Cerebrospinal Fluid Management Market, by CSF Drainage Systems – Revenue and Forecast to 2028 (USD Million)
Table 16. France Cerebrospinal Fluid Management Market, by End User – Revenue and forecast to 2028 (USD Million)
Table 17. Spain Cerebrospinal Fluid Management Market, by Product– Revenue and forecast to 2028 (USD Million)
Table 18. Spain Cerebrospinal Fluid Management Market, by CSF Shunts – Revenue and Forecast to 2028 (USD Million)
Table 19. Spain Cerebrospinal Fluid Management Market, by CSF Drainage Systems – Revenue and Forecast to 2028 (USD Million)
Table 20. Spain Cerebrospinal Fluid Management Market, by End User – Revenue and forecast to 2028 (USD Million)
Table 21. Italy Cerebrospinal Fluid Management Market, by Product– Revenue and forecast to 2028 (USD Million)
Table 22. Italy Cerebrospinal Fluid Management Market, by CSF Shunts – Revenue and Forecast to 2028 (USD Million)
Table 23. Italy Cerebrospinal Fluid Management Market, by CSF Drainage Systems, 2019- 2028 (USD Million)
Table 24. Italy Cerebrospinal Fluid Management Market, by End User – Revenue and forecast to 2028 (USD Million)
Table 25. Rest of Europe: Cerebrospinal Fluid Management Market, by Product– Revenue and forecast to 2028 (USD Million)
Table 26. Rest of Europe Cerebrospinal Fluid Management Market, by CSF Shunts – Revenue and Forecast to 2028 (USD Million)
Table 27. Rest of Europe Cerebrospinal Fluid Management Market, by CSF Drainage Systems – Revenue and Forecast to 2028 (USD Million)
Table 28. Rest of Europe Cerebrospinal Fluid Management Market, by End User – Revenue and forecast to 2028 (USD Million)
Table 29. Organic Developments Done by Companies
Table 30. Inorganic Developments Done by Companies
Table 31. Glossary of Terms, Cerebrospinal Fluid Management Market
LIST OF FIGURES
Figure 1. Cerebrospinal Fluid Management Market Segmentation
Figure 2. Cerebrospinal Fluid Management Market – By Country
Figure 3. Cerebrospinal Fluid Management Market Overview
Figure 4. CSF Shunts Segment Held Largest Share of Cerebrospinal Fluid Management Market by Product
Figure 5. Cerebrospinal Fluid Management Market – Leading Country Markets (US$ Million)
Figure 6. Europe: PEST Analysis
Figure 7. Expert Opinion
Figure 8. Cerebrospinal Fluid Management Market Impact Analysis of Drivers and Restraints
Figure 9. Europe Cerebrospinal Fluid Management Market – Revenue Forecast and Analysis – 2021- 2028
Figure 10. Cerebrospinal Fluid Management Market Revenue Share, by Product (2021 and 2028)
Figure 11. CSF Shunts: Cerebrospinal Fluid Management Market– Revenue and Forecast to 2028 (US$ Million)
Figure 12. Ventriculo-Peritoneal Shunts: Cerebrospinal Fluid Management Market– Revenue and Forecast to 2028 (US$ Million)
Figure 13. Ventriculo-Atrial Shunts: Cerebrospinal Fluid Management Market– Revenue and Forecast to 2028 (US$ Million)
Figure 14. Ventriculo-Pleural Shunts: Cerebrospinal Fluid Management Market– Revenue and Forecast to 2028 (US$ Million)
Figure 15. Lumbo-Peritoneal Shunts: Cerebrospinal Fluid Management Market– Revenue and Forecast to 2028 (US$ Million)
Figure 16. CSF Drainage Systems: Cerebrospinal Fluid Management Market– Revenue and Forecast to 2028 (US$ Million)
Figure 17. External Ventricular Drainage (EVD) Systems: Cerebrospinal Fluid Management Market– Revenue and Forecast to 2028 (US$ Million)
Figure 18. Lumbar Drainage (LD) Systems: Cerebrospinal Fluid Management Market– Revenue and Forecast to 2028 (US$ Million)
Figure 19. Cerebrospinal Fluid Management Market Revenue Share, by End User (2021 and 2028)
Figure 20. Hospitals: Cerebrospinal Fluid Management Market– Revenue and Forecast to 2028 (US$ Million)
Figure 21. Clinics: Cerebrospinal Fluid Management Market– Revenue and Forecast to 2028 (US$ Million)
Figure 22. Ambulatory Surgical Centers: Cerebrospinal Fluid Management Market– Revenue and Forecast to 2028 (US$ Million)
Figure 23. Neurological centers: Cerebrospinal Fluid Management Market– Revenue and Forecast to 2028 (US$ Million)
Figure 24. Europe: Cerebrospinal Fluid Management Market, by Key Country – Revenue (2021) (USD Million)
Figure 25. Europe Cerebrospinal Fluid Management Market Revenue and forecast to 2028 (USD Million)
Figure 26. Europe: Cerebrospinal Fluid Management Market, by Country, 2021 & 2028 (%)
Figure 27. Germany: Cerebrospinal Fluid Management Market – Revenue and forecast to 2028 (USD Million)
Figure 28. UK: Cerebrospinal Fluid Management Market – Revenue and forecast to 2028 (USD Million)
Figure 29. France: Cerebrospinal Fluid Management Market – Revenue and forecast to 2028 (USD Million)
Figure 30. Spain: Cerebrospinal Fluid Management Market – Revenue and forecast to 2028 (USD Million)
Figure 31. Italy: Cerebrospinal Fluid Management Market – Revenue and forecast to 2028 (USD Million)
Figure 32. Rest of Europe: Cerebrospinal Fluid Management Market – Revenue and forecast to 2028 (USD Million)
Figure 33. Impact of COVID-19 Pandemic in European Country Markets
- Medtronic
- Integra Life Sciences Corporation
- B. Braun Melsungen AG
- DePuy Synthes
- Sophysa
- Dispomedica GmbH
- Möller Medical GmbH
- Natus Medical Incorporated
- Spiegelberg GmbH & Co. KG
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.